Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Gentian Diagnostics ASA ( (DE:6FK) ) has provided an announcement.
Carpe Diem Afseth AS has acquired 10,000 shares in Gentian Diagnostics ASA, bringing its total ownership to 5.01% of the company’s issued shares and voting rights. This acquisition highlights Carpe Diem’s growing interest in Gentian, potentially impacting the company’s shareholder dynamics and market perception.
More about Gentian Diagnostics ASA
Average Trading Volume: 9,697
Current Market Cap: NOK879.1M
For an in-depth examination of 6FK stock, go to TipRanks’ Stock Analysis page.